A dual compression system: preliminary clinical insights from the US
John C Lantis1, Christopher Barrett2, Kara S Couch3
1Mount Sinai Morningside and West Hospitals, Icahn School of Medicine, New York, US.
Journal of Wound Care
|September 14, 2020
Summary
Compression therapy, particularly the UrgoK2 system, effectively treats venous leg ulcers and edema. This dual-layer system offers sustained pressure, improving venous return and wound healing with promising initial clinical feedback.
Area of Science:
- Vascular Medicine
- Dermatology
- Wound Care
Background:
- Venous leg ulceration is linked to venous and lymphatic system dysfunction, with edema and lymphatic impairment delaying healing.
- Compression therapy is standard for venous and lymphatic disorders, reducing recurrence and improving venous return.
- The static stiffness index (SSI) quantifies bandage pressure changes during activity, with higher SSI indicating greater hemodynamic benefit.
Purpose of the Study:
- To present the initial clinical experience of US health professionals with the UrgoK2 dual-layer compression system.
- To evaluate the efficacy and application of a novel compression system for venous leg ulcers and edema.
Main Methods:
- The UrgoK2 system, a dual-layer bandage (inelastic and elastic), provides sustained resting and elevated working pressures.
- It is designed for treating active venous leg ulcers and reducing chronic venous edema.
- Each layer features a visual aid for correct pressure application.
Main Results:
- Published European studies have assessed the system's consistency, tolerability, and efficacy.
- This article reports the first US clinical experiences with the UrgoK2 system.
- Initial feedback from US health professionals is promising.
Conclusions:
- The UrgoK2 dual-layer compression system shows promise in the US market for managing venous leg ulcers and edema.
- Its design facilitates consistent application and provides sustained therapeutic pressure.
- Further clinical data will confirm its long-term efficacy and benefits in US patient populations.


